InflaRx Receives Approval to Initiate Phase IIa Clinical Trial with Lead Candidate IFX-1 in Pyoderma Gangraenosum

February 27, 2019

We're not around right now. But you can send us an email and we'll get back to you, asap.

Start typing and press Enter to search